. Thin-layer chromatography (TLC) of control studies. 
Unstapling short peptide CAAAC
Short peptide CAAAC was synthesised with solid-phase peptide synthesis method following previously reported method [1] . DPAP (0.6 mg, 2.4 µmol 1.0 equiv) and 1-thio-β-D-glucose tetraacetate, 4AcGlcSH, (8.9 mg, 0.024 mmol, 10.0 equiv) was dissolved to a solution of stapled 
Largazole synthesis and decaging
The Largazole thiol was synthesised following several reported routes. (Scheme 1-4) 
Synthesis of ethyl 2-[N-(tert-butoxycarbonyl)aminomethyl]thiazole-4-carboxylate (C1)
Ethyl bromopyruvate (0.84 mL, 6.7 mmol, 1.2 equiv) and calcium carbonate (0.56 g, 5.6 mmol, 1 equiv) were added in sequence to a solution of tert-butyl 2-amino-2-thioxoethylcarbamate C0 (1.06 g, 5.6 mmol, 1 equiv) in ethanol (20 mL) at room temperature. The reaction mixture was stirred for 7 h at room temperature. The product mixture was concentrated, and the residue obtained was purified by flash-column chromatography (petroleum ether 40-60/ethyl acetate, 8:1 to 2:1) to furnish the thiazole C1 as a white solid (1.02 g, 65%). 1 The preparation was followed the reference and the characterization was in agreement with those reported [2] .
Synthesis of 2-[N-(tert-butoxycarbonyl)aminomethyl]thiazole-4-carboxamide (C2)
A solution of aqueous ammonia (28% w/v, 42 mL) was added to a solution of the thiazole C1 (1.01 g, 3.5 mmol, 1 equiv) in anhydrous methanol (35 mL) at room temperature. The resulting mixture was stirred overnight at room temperature. The product mixture was concentrated and the residue obtained was dried by azeotropic distillation from toluene (50 mL*2) to afford the product C2 as a yellow solid (0.87 g, 96% The preparation was followed the reference and the characterization was in agreement with those reported [2] .
Synthesis of 2-[N-(tert-butoxycarbonyl)aminomethyl]thiazole-4-carbonitrile (C3)
Trifluoroacetic anhydride (0.51 mL, 3.6 mmol, 1.1 equiv) was added dropwise over 20 min to a solution of the amide C1 (0.086 g, 3.3 mmol, 1 equiv) and triethylamine (1.0 mL, 7.26 mmol, 2.20 equiv) in dichloromethane (50 mL) at 0 °C. The resulting mixture was stirred for 30 min at 0 °C.
The reaction mixture was then allowed to warm over 30 min to room temperature. The reaction mixture was stirred for 2 h at room temperature. The product mixture was concentrated, and the The preparation was followed the reference and the characterization was in agreement with those reported [2] .
Synthesis of (R)-2-(2-((tert-butoxycarbonylamino)methyl)thiazol-4-yl)-4-methyl-4,5-dihydrothiazole-4-carboxylic acid (C4)
Triethylamine (0.37 mL, 2.65 mmol, 1.6 equiv) was added dropwise to a solution of the nitrile C3 (395.6 mg, 1.65 mmol, 1 equiv) and 2-methyl-L-cysteine (454.0 mg,2.65 mmol, 1.6 equiv) in methanol (25 mL) at room temperature. The reaction mixture was heated at reflux overnight. The product mixture was cooled to room temperature and the cooled prod uct mixture was concentrated. The residue obtained was dissolved in saturated aqueous sodium bicarbonate solution (40 mL) and the resulting solution was washed with ether (30 mL). The aqueous layer was acidified to pH 3~4 by the dropwise addition of 3.0 N aqueous hydrochloric acid solution. The resulting mixture was extracted with ethyl acetate (3*30 mL) and the organic layers were combined. The combined organic layers were dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated to provide the thiazole-thiazoline C4 as a white solid (590.9 mg, 100%). The preparation was followed the reference and the characterization was in agreement with those reported [3] . The preparation was followed the reference and the characterization was in agreement with those reported [4] .
Synthesis of (2E)-5-[(triphenylmethyl)thio]-2-pentenal (A2)
To a solution of triphenylmethanethiol (2.7 g, 9.8 mmol, 2.09 equiv) in dichloromethane (100 mL) was added acrolein A0 (0.8 g, 13.6 mmol, 2.9 equiv) and triethylamine (1.4 g, 13.6 mmol, 2.9 equiv). The resulting mixture was stirred for 1 h at room temperature and was concentrated to
give the aldehyde A1 as a white solid, which was used in the next step without purification. A The preparation was followed the reference and the characterization was in agreement with those reported [5] .
Synthesis of 3S-hydroxy-1-(4R-benzyl-2-thioxothiazolidin-3-yl)-7-tritylsulfanylhept-4E-en-1-one (A3)
To a solution of acetyl Nagao chiral auxiliary (2. The preparation was followed the reference and the characterization was in agreement with those reported [5] .
Synthesis of (3S,4E)-3-hydroxy-7-[(triphenylmethyl)thio]-4-heptenoic acid (2-trimethylsilyl)ethyl ester (A4)
To a solution of thiazoline-thione A3 (0.21g, 0.34 mmol, 1 equiv) was dissolved in 5 mL The preparation was followed the reference and the characterization was in agreement with those reported [3] . The preparation was followed the reference and the characterization was in agreement with those reported [6] .
Synthesis of (S,E)-2-(trimethylsilyl)ethyl 3-(((S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanoyl)oxy)-7-(tritylthio)hept-4-enoate (AB1)
TrtS
Synthesis of (3S,4E)-2-(trimethylsilyl)ethyl-3-[(S)-2-((R)-2-{2-[(tert-butoxycarbonyl)methyl]thiazol-

4-yl}-4-methyl-4,5-dihydrothiazole-4-carboxamido)-3-methylbutanoyloxy]-7-(tritylthio)hept-4-enoate (ABC1)
To a solution of Fmoc protected amine AB1 (1.16 g, 1.38 mmol, 1 equiv) in acetonitrile (70 mL) at room temperature was added diethylamine (7.0 mL). The preparation was followed the reference and the characterization was in agreement with those reported [3, 6a] .
Synthesis of S-trityl macrocycle (ABC3)
To a solution of linear precursor ABC1 (0.10 g 0.104 mmol, 1 equiv) in dichloromethane (5 mL) at The preparation was followed the reference and the characterization was in agreement with those reported [3] .
Synthesis of Largazole Thiol
The S-trityl macrocycle ABC3 (40.0 mg, 0.054 mmol, 1 equiv) was dissolved in dry dichloromethane (7 mL) and cooled to 0 o C. The mixture was successively treated with iPr3SiH The preparation was followed the reference and the characterization was in agreement with those reported [3] .
Synthesis of Largazole
To a stirred solution of Largazole Thiol (14. The preparation was followed the reference and the characterization was in agreement with those reported [7] . 
Synthesis of Stapled Largazole
Largazole Thiol (9.0 mg, 0.018 mmol, 2 equiv) and potassium carbonate (6.3 mg, 0.045 mmol, 5 equiv) were dissolved in DMF (1 mL). 3-Bromo-2-bromomethyl-1-propene (0.52 µL, 0.005 mmol, 0.5 equiv) was added to the stirred solution. After being stirred at room temperature for 2 h, the same amount of 3-bromo-2-bromomethyl-1-propene was added and stirred for another 5 h. After this, the reaction was diluted with Et2O (10 mL) and washed sequentially with a saturated solution of LiBr (10 mL) and brine (10 mL). The organic layer was dried with magnesium sulphate, filtered, and concentrated under reduced pressure. The resulting residue was purified by flash-column chromatography (ethyl acetate) to provide the Stapled Largazole (6.5 mg, 69%) as white solid. 
Synthesis of Unstapled Largazole thiol
Computational Details
Full geometry optimizations and transition structure (TS) searches were carried out with Gaussian 16 [8] using the M06-2X hybrid functional [9] and 6-311++G(2d,p) basis set with ultrafine integration grids. Bulk solvent effects in water were considered implicitly through the IEF-PCM polarizable continuum model. [10] Radical species were calculated as open-shell doublets. The possibility of different conformations was taken into account for all structures. All stationary points were characterized by a frequency analysis performed at the same level used in the geometry optimizations from which thermal corrections were obtained at 298.15 K. The quasiharmonic approximation reported by Truhlar et al. was used to replace the harmonic oscillator approximation for the calculation of the vibrational contribution to enthalpy and entropy. [11] Scaled frequencies were not considered. Mass-weighted intrinsic reaction coordinate (IRC) calculations were carried out by using the Gonzalez and Schlegel scheme [12] in order to ensure that the TSs indeed connected the appropriate reactants and products. Gibbs free energies (ΔG)
were used for the discussion on the relative stabilities of the considered structures. 
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Biological Assays Parallel Artificial Membrane Permeability Assay (PAMPA)
The PAMPA Evolution TM instrument was used to determine permeability. In PAMPA, a sandwich is formed such that each composite well is divided into two chambers, separated by a 125 μm thick microfilter disc (0.45 μm pores), coated with Pion GIT-0 phospholipid mixture. The effective permeability, Pe, of each compound was measured at the customer-specified pHs in the donor compartment using low-binding, low UV Prisma buffer. The drug-free acceptor compartment was filled with acceptor sink buffer containing a scavenger at the start of the test. The proprietary scavenger mimics serum proteins and blood circulation, thus creating sink conditions.
In the default protocol the aqueous solutions of studied compounds are prepared by diluting and thoroughly mixing 3 μL of DMSO stock in 600 μL of Prisma HT buffer. Final concentration of organic solvent (DMSO) in aqueous buffer is ≤ 0.5% (v/v).
The reference solution is identical to the donor at time zero, so that any surface adsorption effects from the plastic is compensated. The PAMPA sandwich was assembled and allowed to incubate for ~15 hours. The solutions in the donor compartment were un-stirred within duration of the experiment. Thus, the thickness of the aqueous boundary layer expected to be about 1000 μm. The sandwich was then separated, and both the donor and receiver compartments were assayed for the amount of drug present by comparison with the UV spectrum obtained from reference standards. Mass balance was used to determine the amount of material remaining in the membrane filter and on the plastic (%R). Ketoprofen, Verapmil and Propanolol were used as reference compounds.
Buffers preparation
pH of Prisma HT buffer was adjusted to the requested values using 1.0 M solution of NaOH. Actual pH the buffers was 7.40 ± 0.05.
Stock solutions preparation
Sample powders pre-weighed in glass vials were brought to the room temperature at the day of the experiment. The samples were diluted with an organic solvent (DMSO) to prepare stock solutions at concentration ~10 mM. The stock solutions were further diluted in buffer at 7.40 S23 producing the aqueous sample solutions at concentrations ~50 μM. The amount of DMSO in the resulting solution was <0.5% (v/v). The solutions were filtered prior assaying the samples. 
Histone Deacetylase (HDAC) Activity Assay (Fluorometric)
Following the measurement of the cell viability, the plates were washed with cold PBS for three times. Then, the whole-cell lysates were prepared on ice using RIPA Lysis and Extraction Buffer 
